MAZE FY 2023 Earnings — Maze Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

MAZEMaze Therapeutics, Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$99M

Net Income

-$100M

EPS (Diluted)

$-2.29

Cash Flow

Operating Cash Flow

-$87M

Free Cash Flow

-$87M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$72M

Total Liabilities

$61M

Stockholders' Equity

$10M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$99M	-$111M	+11.2%
Net Income	-$100M	-$115M	+12.6%